Zobrazeno 1 - 6
of 6
pro vyhledávání: '"T. A. Vandenberg"'
Autor:
Nicole L. Michmerhuizen, N Jawad, T R Vandenberg, Megan L. Ludwig, M.E. Spector, J.C. Brenner, Andrew G. Shuman, Rebecca C. Hoesli, Michelle Mierzwa, Jacqueline E. Mann, Samantha N. Devenport, Chloe Matovina
Publikováno v:
Journal of Cancer
Immunotherapy is becoming an accepted treatment modality for many patients with cancer and is now approved for use in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Despite these successes, a minority of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd31e91248aea8cc28ed55054ca75dc
https://doi.org/10.7150/jca.17547
https://doi.org/10.7150/jca.17547
Autor:
J M, Nabholtz, H J, Senn, W R, Bezwoda, D, Melnychuk, L, Deschênes, J, Douma, T A, Vandenberg, B, Rapoport, R, Rosso, V, Trillet-Lenoir, J, Drbal, A, Molino, J W, Nortier, D J, Richel, T, Nagykalnai, P, Siedlecki, N, Wilking, J Y, Genot, P S, Hupperets, F, Pannuti, D, Skarlos, E M, Tomiak, M, Murawsky, M, Alakl, M, Aapro
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(5)
This phase III study compared docetaxel with mitomycin plus vinblastine (MV) in patients with metastatic breast cancer (MBC) progressing despite previous anthracycline-containing chemotherapy.Patients (n=392) were randomized to receive either docetax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09aba86a5914568791f9beb597e19b93
https://pubmed.ncbi.nlm.nih.gov/10334526
https://pubmed.ncbi.nlm.nih.gov/10334526
Autor:
N. Wilking, P. Siedlecki, Matti Aapro, T. A. Vandenberg, R. Rosso, D. Melnychuk, Michael Murawsky, J.-M. Nabholtz, F. Pannuti, Annamaria Molino, H. J. Senn, Johan W. R. Nortier, D. Skarlos, J. Douma, T. Nagykalnai, M. Alakl, J. Drbal, Alessandro Riva, J. Y. Genot, Eva Tomiak, Dick J. Richel, L. Deschenes, Bernardo Leon Rapoport, P.S.G.J. Hupperets, V. Trillet-Lenoir, W. R. Bezwoda
Publikováno v:
Scopus-Elsevier
PURPOSE: This phase III study compared docetaxel with mitomycin plus vinblastine (MV) in patients with metastatic breast cancer (MBC) progressing despite previous anthracycline-containing chemotherapy. PATIENTS AND METHODS: Patients (n = 392) were ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a03349ab92b2569dc2f4f438029db281
http://hdl.handle.net/11562/309588
http://hdl.handle.net/11562/309588
Autor:
J M, Nabholtz, B, Thuerlimann, W R, Bezwoda, D, Melnychuk, L, Deschênes, J, Douma, T A, Vandenberg, B, Rapoport, R, Rosso, V, Trillet-Lenoir, J, Drbal, M S, Aapro, M, Alaki, M, Murawsky, A, Riva
Publikováno v:
Oncology (Williston Park, N.Y.). 11(8 Suppl 8)
This nonblinded, multicenter, randomized phase III study compares the median time to progression (primary endpoint), response rate, and quality of life, safety, and survival of docetaxel (Taxotere) vs mitomycin (Mutamycin) plus vinblastine (Velban) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19f61fb3a0d983034c316ddc0e457505
https://pubmed.ncbi.nlm.nih.gov/9364538
https://pubmed.ncbi.nlm.nih.gov/9364538
Publikováno v:
Cancer preventioncontrol : CPC = Preventioncontrole en cancerologie : PCC. 1(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f84780811111be844ef4bec9fb71118
https://pubmed.ncbi.nlm.nih.gov/9765739
https://pubmed.ncbi.nlm.nih.gov/9765739
Autor:
T A, Vandenberg, J A, Maroun
Publikováno v:
Canadian Medical Association journal. 132(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96faf65cd6c834638a46b993b01f9b61
https://pubmed.ncbi.nlm.nih.gov/3891059
https://pubmed.ncbi.nlm.nih.gov/3891059